Fig. 1
From: Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study
Study flow diagram. *The target LDL-C value was <2.5 mmol/L until 31 March, 2013, when local guidelines for diabetic patients changed this target to <1.8 mmol/L; †Medication was titrated until target values were reached or no further changes were considered appropriate. n: number of cases; DM: diabetes mellitus; CKD: chronic kidney disease; LDL-C: low-density lipoprotein cholesterol; BP: blood pressure